This suggests c-Met is an important mediator of tumor progression under hypoxia, and this notion was supported by a study reporting that pharmacological inhibition of c-Met abrogates hypoxia-induced invasion in a mouse lung cancer xenograft model [77]. This evidence concerns the gene MET and lung cancer.